
    
      B/F/TAF (bictegravir/FTC/TAF) is an investigational single pill drug treatment drug that
      contains neither TDF nor EFV. This study is looking at whether changing people to this new
      drug treatment will continue to suppress their HIV and have fewer side effects.
    
  